Filed by Reynolds American Inc.
Commission File No. 1-32258
Pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: Lorillard, Inc.
Commission File No. 001- 34097
Date: October 21, 2014
Reynolds American Inc.
P.O. Box 2990
Winston-Salem, NC 27102-2990
| Contact: | Investor Relations: Morris Moore (336) 741-3116 | Media: Jane Seccombe (336) 741-5068 | RAI 2014-25 |
Strong broad-based growth
drives RAI’s 3Q14 earnings higher;
Company reaffirms full-year guidance
WINSTON-SALEM, N.C. – Oct. 21, 2014
Third Quarter 2014 – At a Glance
• Adjusted EPS: Third quarter at $0.95, up 10.5 percent from prior-year quarter; nine months at $2.55, up 5.4 percent
¡ Excludes transaction-related and financing costs, charges for Engle progeny lawsuits and implementation costs, and other special items*
• Reported EPS: Third quarter at $0.88, up 4.8 percent; nine months at $2.47, down 5.0 percent
• RAI reaffirms 2014 guidance: Adjusted EPS range of $3.35 to $3.45
¡ Excludes transaction-related and financing costs, one-time benefit from NPM Partial Settlement, gain from discontinued operations and charges for implementation costs, Engle progeny lawsuits and other tobacco-related litigation
• All reportable business segments increase earnings and margin
• Additional highlights:
¡ RAI announced Lorillard, Inc. acquisition on July 15
¡ R.J. Reynolds Vapor Company accelerated VUSE national expansion
¡ Niconovum USA began national distribution of ZONNIC gum
¡ RAI selected to 2014-2015 Dow Jones Sustainability North America Index
* Special items are detailed in Schedule 2 and include a one-time benefit from the partial settlement of the Master Settlement Agreement (MSA) Non-Participating Manufacturer (NPM) adjustment claims (NPM Partial Settlement), a gain from discontinued operations and charges for implementation costs, Engle progeny lawsuits and other tobacco-related litigation, as well as the 2013 one-time benefit from the NPM Partial Settlement.
All references in this release to “reported” numbers refer to GAAP measurements; all “adjusted” numbers are non-GAAP, as defined in Schedules 2 and 3 of this release, which reconcile reported to adjusted results.
|
1
Reynolds American Inc. (NYSE: RAI) today announced third-quarter 2014 adjusted EPS of $0.95, up 10.5 percent from the prior-year quarter, as higher cigarette and moist-snuff pricing, and the ongoing benefit from the partial settlement of certain NPM Adjustment claims, more than offset lower cigarette volume and increased investment on the VUSE Digital Vapor Cigarette.
Adjusted EPS excludes transaction-related and financing costs, implementation costs, and charges forEngle progeny lawsuits. Reported third-quarter EPS was $0.88, up 4.8 percent.
For the first nine months of 2014, adjusted EPS was $2.55, up 5.4 percent from the prior-year period, while reported EPS was $2.47, down 5.0 percent. Nine-month adjusted results exclude the above-referenced items, as well as a one-time benefit from the NPM Partial Settlement, a gain on discontinued operations, and charges for other tobacco-related litigation.
RAI reaffirmed 2014 adjusted EPS guidance in the range of $3.35 to $3.45, up 5.0 percent to 8.2 percent from 2013’s adjusted EPS of $3.19.
Third Quarter 2014 Financial Results – Highlights
(unaudited)
(all dollars in millions, except per-share amounts;
for reconciliations, including GAAP to non-GAAP, see Schedules 2 and 3)
| For the Three Months Ended Sept. 30 | For the Nine Months Ended Sept. 30 | |||||||||||||||||||||
| 2014 | 2013 | % Change | 2014 | 2013 | % Change | |||||||||||||||||
Net sales | $2,240 | $2,135 | 4.9% | $6,337 | $6,197 | 2.3% | ||||||||||||||||
Operating income
| ||||||||||||||||||||||
Reported (GAAP)
|
| $ 812
|
|
| $ 791
|
| 2.7%
|
| $ 2,238
|
|
| $ 2,476
|
|
| (9.6)%
|
| ||||||
Adjusted (Non-GAAP) | 852 | 808 | 5.4% | 2,325 | 2,298 | 1.2% | ||||||||||||||||
Net income
| ||||||||||||||||||||||
Reported (GAAP)
|
| $ 467
|
|
| $ 457
|
| 2.2%
|
| $ 1,322
|
|
| $ 1,426
|
|
| (7.3)%
|
| ||||||
Adjusted (Non-GAAP) | 505 | 468 | 7.9% | 1,365 | 1,328 | 2.8% | ||||||||||||||||
Net income per diluted share
| ||||||||||||||||||||||
Reported (GAAP)
|
| $0.88
|
|
| $0.84
|
| 4.8%
|
| $2.47
|
|
| $2.60
|
|
| (5.0)%
|
| ||||||
Adjusted (Non-GAAP) | 0.95 | 0.86 | 10.5% | 2.55 | 2.42 | 5.4% | ||||||||||||||||
2
MANAGEMENT’S PERSPECTIVE
Overview
“I’m very pleased to report another strong performance by our operating companies, which drove Reynolds American’s earnings and margin higher in the third quarter,” said Susan M. Cameron, president and chief executive officer of RAI. “All of our reportable business segments increased both profit and margin during the quarter, while they continued to enhance their powerful key brands.”
In addition, management’s focus on building long-term sustainability as part of the company’s transforming tobacco strategy gained further momentum in the third quarter, with promising results from the national roll-out of innovative nicotine-based products.
“The expansion of R.J. Reynolds Vapor Company’s VUSE Digital Vapor Cigarette is going very well,” Cameron said. “VUSE will be available in almost 70,000 selected retail outlets by early next week, and that will be followed by another wave of expansion early next year.”
Niconovum USA began national distribution of its ZONNIC gum, a nicotine-replacement therapy product, in September. “I’m pleased to say that early results are positive, with strong interest from retailers and smokers,” Cameron said. “ZONNIC is expected to be in about 8,000 selected outlets by the end of this month, and its retail availability will continue to grow through the rest of the year.”
Another highlight of the quarter was RAI’s selection again to the Dow Jones Sustainability North America Index. “We greatly value this independent recognition of our companies’ wide-ranging sustainability efforts as it demonstrates our commitment to sustainability across all aspects of our business,” she said.
With the end of the year in sight, RAI reaffirmed its 2014 guidance, with expected adjusted EPS growth of 5.0 percent to 8.2 percent over 2013’s adjusted results. This projection takes into account the investments on VUSE, as well as continued equity-building initiatives on RAI’s operating companies’ key brands.
“Our results demonstrate the substantial progress we’ve made this year in strengthening our core businesses and returning value to our shareholders, and our companies continue to enhance their prospects for long-term growth,” Cameron said.
Cameron said that RAI continues to diligently work to obtain the necessary regulatory, shareholder and other approvals for the company’s proposed acquisition of Lorillard, Inc. and divestiture of select brands and assets to a subsidiary of Imperial Tobacco Group PLC (“the Proposed Transaction/s”).
“RAI is currently responding to a second request for additional information from the U.S. Federal Trade Commission, and the company recently filed its preliminary joint proxy statement/prospectus with the U.S. Securities and Exchange Commission,” she said. “This process is proceeding smoothly, and we remain confident that the transaction will be completed by mid-2015.”
3
RJR Tobacco
RJR Tobacco’s third-quarter adjusted operating income increased 14.6 percent from the prior-year quarter, to $748 million, as higher pricing and lower MSA cost more than offset a decline in cigarette volume. Adjusted results exclude implementation costs and charges forEngle progeny lawsuits.
For the first nine months, the company’s adjusted operating income was up 6.6 percent from the prior-year period, at $2.0 billion. Adjusted results exclude the above-referenced items, as well as a one-time benefit from the NPM Partial Settlement.
RJR Tobacco’s third-quarter adjusted operating margin increased 4.1 percentage points from the prior-year quarter, to 41.6 percent, bringing nine-month adjusted operating margin to 39.2 percent, up 2.4 percentage points.
RJR Tobacco’s third-quarter cigarette shipments declined 2.9 percent from the prior-year quarter, and were down 5.1 percent for the first nine months. Industry volumes were down 2.3 percent in the quarter, and down 3.5 percent for the nine-month period. When adjusted for wholesale inventory changes, RJR Tobacco’s third-quarter shipments were down about 4.3 percent, and industry volumes were down about 2.7 percent for the quarter.
RJR Tobacco’s total cigarette market share was down 0.1 percentage point from the prior-year quarter, at 26.6 percent, supported by solid performance on Camel and Pall Mall, the company’s growth brands.
On a combined basis, Camel and Pall Mall increased their total share by 0.3 percentage points, to 19.7 percent. These brands make up over 70 percent of the company’s total cigarette market share.
Camel increased third-quarter market share by 0.4 percentage points from the prior-year quarter, to 10.4 percent, on volume growth of 3.0 percent. The brand delivered solid performance across both its regular and menthol styles.
Camel continues to strengthen its core brand equity, while retaining a very favorable demographic profile.
Pall Mall, the nation’s No. 1 value brand and fourth-largest cigarette brand overall, saw a slight share decline of 0.1 percentage point from the prior-year quarter, to 9.3 percent.
Pall Mall’s packaging has just been upgraded, reflecting a more contemporary and premium look and feel for all its styles. The brand has seen tremendous growth in recent years, with a conversion rate of about 50 percent among adult smokers who try the brand. Pall Mall’s positioning as a longer-lasting cigarette at an affordable price appeals to value-conscious smokers.
4
American Snuff
American Snuff’s third-quarter operating income increased 10.9 percent from the prior-year quarter, to $117 million. This brought nine-month operating income to $329 million, up 6.5 percent from the adjusted prior-year period.
American Snuff’s third-quarter operating margin increased by 0.8 percentage points to 57.8 percent, bringing nine-month adjusted operating margin to 56.4 percent.
Prior-year adjusted results exclude implementation costs for the nine-month period.
The company’s third-quarter moist-snuff volume increased 2.9 percent from the prior-year quarter, with moist-snuff industry volume growing between 3 percent and 4 percent. The company’s moist-snuff market share declined by 0.1 percentage point in the quarter, to 34.0 percent.
American Snuff’s flagship Grizzly brand continued to perform well in a highly competitive promotional environment, increasing third-quarter market share by 0.1 percentage point from the prior-year quarter, to 31.1 percent, on volume growth of 3.6 percent. American Snuff continues to refine Grizzly’s approach to balancing share and earnings growth, while investing in equity-building initiatives to further enhance the brand.
Santa Fe
Santa Fe increased third-quarter operating income by 19.1 percent from the prior-year quarter, to $98 million, again benefiting from higher volume and pricing.
For the first nine months, the company’s operating income increased 19.2 percent from the adjusted prior-year period, to $247 million. Adjusted prior-year results exclude implementation costs and a one-time benefit from the NPM Partial Settlement.
Santa Fe’s third-quarter operating margin increased 3.5 percentage points from the prior-year quarter, to 54.5 percent, with a nine-month operating margin of 51.1 percent.
Natural American Spirit, the nation’s No. 1 super-premium brand, turned in another strong performance in both volume and market share. This undiscounted brand increased third-quarter market share by 0.2 percentage points from the prior-year quarter, to 1.7 percent, and reported a volume increase of 7.9 percent.
Natural American Spirit offers distinctive additive-free natural tobacco styles, including styles made with organic tobacco.
5
FINANCIAL UPDATE
Reynolds American’s third-quarter adjusted EPS of $0.95 was up 10.5 percent from the prior-year quarter, as higher pricing, the ongoing benefit from the partial settlement of certain NPM Adjustment claims, and the impact of the share repurchase program more than offset cigarette volume declines and increased investment for the VUSE expansion.
Adjusted EPS excludes transaction-related and financing costs of $0.05 and charges of $0.02 forEngle progeny lawsuits.
On a reported basis, third-quarter EPS was $0.88, up 4.8 percent.
For the first nine months, adjusted EPS was $2.55, up 5.4 percent from the prior-year period. This excludes the previously-referenced items, as well as a one-time benefit from the NPM Partial Settlement, a gain on discontinued operations, implementation costs, and charges for other tobacco-related litigation.
On a reported basis, nine-month EPS was down 5.0 percent at $2.47.
RAI’s third-quarter adjusted operating margin rose 0.2 percentage points from the prior-year quarter, to 38.0 percent, reflecting the above-referenced items. That brought nine-month adjusted operating margin to 36.7 percent.
The company ended the quarter with cash balances of $1.3 billion.
Thomas R. Adams, RAI’s chief financial officer, said that, based on the company’s year-to-date performance, RAI is reaffirming its guidance for the year. “We continue to expect 2014 adjusted EPS in the range of $3.35 to $3.45,” he said.
This guidance excludes transaction-related and financing costs, the one-time benefit from the NPM Partial Settlement, the gain from discontinued operations, and charges for implementation costs,Engle progeny lawsuits and other tobacco-related litigation. Guidance also reflects the investment on VUSE, as well as initiatives that continue to build the equity of RAI’s operating companies’ key brands.
CONFERENCE CALL WEBCAST TODAY
Reynolds American will webcast a conference call to discuss third-quarter 2014 results at 9:00 a.m. Eastern Time on Tuesday, Oct. 21, 2014. The call will be available live online on a listen-only basis. To register for the call, please go tohttp://www.reynoldsamerican.com/events.cfm. A replay of the call will be available on the site. Investors, analysts and members of the news media can also listen to the live call by phone, by dialing (877) 390-5533 (toll free) or (678) 894-3969 (international). Remarks made during the conference call will be current at the time of the call and will not be updated to reflect subsequent material developments. Although news media representatives will not be permitted to ask questions during the call, they are welcome to monitor the remarks on a listen-only basis. Following the call, media representatives may direct inquiries to Jane Seccombe at (336) 741-5068.
6
WEB DISCLOSURE
RAI’s website,www.reynoldsamerican.com, is the primary source of publicly disclosed news about RAI and its operating companies. We use the website as our primary means of distributing quarterly earnings and other company news. We encourage investors and others to register atwww.reynoldsamerican.com to receive alerts when news about the company has been posted.
RISK FACTORS
Statements included in this report that are not historical in nature are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. When used in this document and in documents incorporated by reference, forward-looking statements include, without limitation, statements regarding financial forecasts or projections, and RAI and its subsidiaries’ expectations, beliefs, intentions or future strategies that are signified by the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. These statements regarding future events or the future performance or results of RAI and its subsidiaries inherently are subject to a variety of risks, contingencies and other uncertainties that could cause actual results, performance or achievements to differ materially from those described in or implied by the forward-looking statements. These risks, contingencies and other uncertainties include:
| • | the substantial and increasing taxation and regulation of tobacco products, including the regulation of tobacco products by the U.S. Food and Drug Administration (FDA); |
| • | the possibility that the FDA will issue regulations prohibiting menthol in cigarettes or the possibility that the FDA will require the reduction of nicotine levels or the reduction or elimination of other constituents, especially if RAI completes the Proposed Transactions, which refers to the completion of the previously announced proposed transactions with RAI, Lorillard, Inc. (Lorillard), Imperial Tobacco Group PLC (Imperial) and British American Tobacco p.l.c. (BAT); |
| • | the possibility that the FDA will issue regulations extending the FDA’s authority over tobacco products to e-cigarettes, subjecting e-cigarettes to restrictions on, among other things, the manufacturing, marketing and sale of such products; |
| • | decreased sales resulting from the future issuance of “corrective communications,” required by the order in theU.S. Department of Justice case on five subjects, including smoking and health, and addiction; |
| • | various legal actions, proceedings and claims relating to the sale, distribution, manufacture, development, advertising, marketing and claimed health effects of tobacco products that are pending or may be instituted against RAI or its subsidiaries; |
| • | the possibility that reports from the U.S. Surgeon General regarding the negative health consequences associated with cigarette smoking and second-hand smoke may result in additional litigation and/or regulation; |
7
| • | the possibility of being required to pay various adverse judgments in theEngle Progeny and/or other litigation; |
| • | the substantial payment obligations with respect to cigarette sales, and the substantial limitations on the advertising and marketing of cigarettes (and of RJR Tobacco’s smokeless tobacco products) under the State Settlement Agreements; |
| • | the possibility that the Arbitration Panel’s Award reflecting the partial resolution of the NPM Adjustment disputes will be vacated or otherwise modified; |
| • | the possibility that the Arbitration Panel’s Final Award with respect to the states found to be non-diligent in connection with the 2003 NPM Adjustment will be vacated or otherwise modified; |
| • | the continuing decline in volume in the U.S. cigarette industry and RAI’s dependence on the U.S. cigarette industry; |
| • | concentration of a material amount of sales with a limited number of customers and potential loss of these customers; |
| • | competition from other manufacturers, including industry consolidations or any new entrants in the marketplace, such as Imperial if it acquires the brands and other assets it has agreed to purchase in the proposed divestiture of certain brands and other assets to Imperial, referred to as the Divestiture, from RAI and Lorillard and their respective subsidiaries; |
| • | increased promotional activities by competitors, including manufacturers of deep-discount cigarette brands; |
| • | the success or failure of new product innovations, including the digital vapor cigarette, VUSE; |
| • | the success or failure of acquisitions or dispositions, which RAI or its subsidiaries may engage in from time to time, including RAI’s proposed acquisition of Lorillard, referred to as the Merger, and the Divestiture; |
| • | the responsiveness of both the trade and consumers to new products, marketing strategies and promotional programs; |
| • | the reliance on outside suppliers to manage certain non-core business processes; |
| • | the reliance on a limited number of suppliers for certain raw materials; |
| • | the cost of tobacco leaf, and other raw materials and other commodities used in products; |
| • | the passage of new federal or state legislation or regulation; |
8
| • | the effect of market conditions on interest rate risk, foreign currency exchange rate risk and the return on corporate cash, or adverse changes in liquidity in the financial markets; |
| • | the impairment of goodwill and other intangible assets, including trademarks; |
| • | the effect of market conditions on the performance of pension assets or any adverse effects of any new legislation or regulations changing pension and postretirement benefits accounting or required pension funding levels; |
| • | the substantial amount of RAI debt, including the additional debt expected to be incurred in connection with the Merger; |
| • | decreases in the credit ratings assigned to RAI, and to the senior unsecured long-term debt of RAI, including an impact arising out of the additional indebtedness assumed or incurred in connection with the Merger; |
| • | changes in RAI’s historical dividend policy; |
| • | the restrictive covenants imposed under RAI’s debt agreements; |
| • | the possibility of natural or man-made disasters or other disruptions, including disruptions in information technology systems or security breaches, that may adversely affect manufacturing or other operations and other facilities or data; |
| • | the loss of key personnel or difficulties recruiting and retaining qualified personnel; |
| • | the inability to protect adequately intellectual property rights; |
| • | the significant ownership interest of Brown & Williamson Holdings, Inc. (B&W), RAI’s largest shareholder, in RAI and the rights of B&W under the governance agreement between the companies; |
| • | the expiration of the standstill provisions of the governance agreement, and the expiration of RAI’s shareholder rights plan on July 30, 2014; |
| • | a termination of the governance agreement or certain provisions in accordance with its terms, including the limitations on B&W’s representation on RAI’s Board and its board committees; |
| • | the expiration of the non-competition agreement between RAI and BAT on July 30, 2014; and |
| • | additional risks, contingencies and uncertainties associated with the Proposed Transactions that could result in the failure of the Proposed Transactions to be completed or, if completed, to have an adverse effect on the results of operations, cash flows and financial position of RAI and its subsidiaries and any anticipated benefits of the Proposed Transactions to RAI shareholders, including: |
9
| ¡ | the failure to obtain necessary regulatory or other approvals for the Merger and Divestiture, or if obtained, the possibility of being subjected to conditions that could reduce the expected synergies and other benefits of the Merger, result in a material delay in, or the abandonment of, the Merger or otherwise have an adverse effect on RAI; |
| ¡ | the obligation to complete the Merger and Divestiture even if financing is not available or is available on terms other than those currently anticipated, including financing less favorable to RAI than its current commitments, due to the absence of a financing condition in connection with the Merger; |
| ¡ | the obligation to complete the Merger and Divestiture even if there are adverse governmental developments with respect to menthol in cigarettes, and once completed, the effect of such adverse governmental developments on RAI’s subsidiaries’ sales of products that contain menthol which represent a substantial portion of RAI’s consolidated net sales; |
| ¡ | the failure to satisfy required closing conditions or complete the Merger and Divestiture in a timely manner; |
| ¡ | the failure to obtain necessary shareholder approvals for the issuance of additional shares of RAI common stock as consideration to Lorillard shareholders in the Merger and to BAT in the subscription and support agreement, adoption of the agreement and plan of merger entered into by RAI, a wholly owned subsidiary of RAI and Lorillard, referred to as the Merger Agreement, and Divestiture; |
| ¡ | the possibility of selling the transferred assets, including the brands currently expected to be divested, or which otherwise might be divested, on terms less favorable than the Divestiture, due to the absence of a condition in connection with the Merger that the Divestiture be completed; |
| ¡ | the possibility of having to include RJR Tobacco’s DORAL brand as part of the Divestiture; |
| ¡ | the effect of the announcement of the Merger and Divestiture on the ability to retain and hire key personnel and maintain business relationships, and on operating results and businesses generally; |
| ¡ | the effect of restrictions placed on RAI’s, Lorillard’s or their respective subsidiaries’ business activities and the limitations put on RAI’s and Lorillard’s ability to pursue alternatives to the Merger pursuant to the Merger Agreement and a purchase agreement, referred to as the Asset Purchase Agreement, between RAI, Imperial and a wholly owned subsidiary of Imperial, referred to as Imperial Sub; |
| ¡ | the possibility of a delay or prevention of the Merger by lawsuits challenging the Merger filed against RAI, the members of the RAI board of directors, Lorillard, the members of the Lorillard board of directors and BAT; |
| ¡ | the reliance of RJR Tobacco on Imperial Sub to manufacture Newport on RJR Tobacco’s behalf for a period of time after the Divestiture; |
10
| ¡ | RAI’s obligations to indemnify Imperial Sub for specified matters and to retain certain liabilities related to the transferred assets; |
| ¡ | the failure to realize projected synergies and other benefits from the Merger and Divestiture; |
| ¡ | the incurrence of significant pre- and post- transaction related costs in connection with the Merger and Divestiture; and |
| ¡ | the occurrence of any event giving rise to the right of a party to terminate the Merger and Divestiture. |
Due to these risks, contingencies and other uncertainties, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Except as provided by federal securities laws, RAI is not required to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
ABOUT US
Reynolds American Inc. (NYSE: RAI) is the parent company of R.J. Reynolds Tobacco Company; American Snuff Company, LLC; Santa Fe Natural Tobacco Company, Inc.; Niconovum USA, Inc.; Niconovum AB; and R.J. Reynolds Vapor Company.
| • | R.J. Reynolds Tobacco Company is the second-largest U.S. tobacco company. R.J. Reynolds’ brands include two of the best-selling cigarettes in the United States: Camel and Pall Mall. These brands, and its other brands, including Winston, Kool, Doral, Salem, Misty and Capri, are manufactured in a variety of styles and marketed in the United States. |
| • | American Snuff Company, LLC is the nation’s second-largest manufacturer of smokeless tobacco products. Its leading brands are Grizzly and Kodiak. |
| • | Santa Fe Natural Tobacco Company, Inc. manufactures and markets Natural American Spirit 100% additive-free natural tobacco products, including styles made with organic tobacco. |
| • | Niconovum USA, Inc. and Niconovum AB market innovative nicotine replacement therapy products in the United States and Sweden, respectively, under the Zonnic brand name. |
| • | R.J. Reynolds Vapor Company makes and markets VUSE e-cigarettes, a highly differentiated vapor product. |
Copies of RAI’s news releases, annual reports, SEC filings and other financial materials, including risk factors containing forward-looking information, are available atwww.reynoldsamerican.com. To learn more about how Reynolds American and its operating companies are transforming the tobacco industry, visitTransforming Tobacco.
(financial and volume schedules follow)
11
Schedule 1
REYNOLDS AMERICAN INC.
Condensed Consolidated Statements of Income - GAAP
(Dollars in Millions, Except Per Share Amounts)
(Unaudited)
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2014 | 2013 | 2014 | 2013 | |||||||||||||
Net sales, external | $ | 2,169 | $ | 2,055 | $ | 6,089 | $ | 5,944 | ||||||||
Net sales, related party | 71 | 80 | 248 | 253 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net sales | 2,240 | 2,135 | 6,337 | 6,197 | ||||||||||||
Cost of products sold | 1,034 | 1,004 | 2,923 | 2,697 | ||||||||||||
Selling, general and administrative expenses | 391 | 339 | 1,168 | 1,020 | ||||||||||||
Amortization expense | 3 | 1 | 8 | 4 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Operating income | 812 | 791 | 2,238 | 2,476 | ||||||||||||
Interest and debt expense | 76 | 66 | 197 | 193 | ||||||||||||
Interest income | (1 | ) | (1 | ) | (3 | ) | (4 | ) | ||||||||
Other (income) expense, net | (10 | ) | 6 | (9 | ) | 6 | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Income from continuing operations before income taxes | 747 | 720 | 2,053 | 2,281 | ||||||||||||
Provision for income taxes | 280 | 263 | 756 | 855 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income from continuing operations | 467 | 457 | 1,297 | 1,426 | ||||||||||||
Income from discontinued operations, net of tax | - | - | 25 | - | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income | $ | 467 | $ | 457 | $ | 1,322 | $ | 1,426 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Basic net income per share: | ||||||||||||||||
Income from continuing operations | $ | 0.88 | $ | 0.84 | $ | 2.43 | $ | 2.61 | ||||||||
Income from discontinued operations | $ | - | $ | - | $ | 0.05 | $ | - | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net Income | $ | 0.88 | $ | 0.84 | $ | 2.48 | $ | 2.61 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted net income per share: | ||||||||||||||||
Income from continuing operations | $ | 0.88 | $ | 0.84 | $ | 2.42 | $ | 2.60 | ||||||||
Income from discontinued operations | $ | - | $ | - | $ | 0.05 | $ | - | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net Income | $ | 0.88 | $ | 0.84 | $ | 2.47 | $ | 2.60 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Basic weighted average shares, in thousands | 531,284 | 542,631 | 533,786 | 546,768 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted weighted average shares, in thousands | 532,917 | 544,650 | 535,521 | 548,701 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Segment data: | ||||||||||||||||
Net sales: | ||||||||||||||||
R.J. Reynolds | $ | 1,799 | $ | 1,737 | $ | 5,098 | $ | 5,087 | ||||||||
American Snuff | 202 | 185 | 581 | 546 | ||||||||||||
Santa Fe | 179 | 160 | 482 | 423 | ||||||||||||
All Other | 60 | 53 | 176 | 141 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
| $ | 2,240 | $ | 2,135 | $ | 6,337 | $ | 6,197 | |||||||||
|
|
|
|
|
|
|
| |||||||||
Operating income: | ||||||||||||||||
R.J. Reynolds | $ | 731 | $ | 635 | $ | 1,939 | $ | 2,056 | ||||||||
American Snuff | 117 | 106 | 329 | 306 | ||||||||||||
Santa Fe | 98 | 82 | 247 | 208 | ||||||||||||
All Other | (88 | ) | (15 | ) | (176 | ) | (38 | ) | ||||||||
Corporate | (46 | ) | (17 | ) | (101 | ) | (56 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
| $ | 812 | $ | 791 | $ | 2,238 | $ | 2,476 | |||||||||
|
|
|
|
|
|
|
| |||||||||
Supplemental information: | ||||||||||||||||
Excise tax expense | $ | 962 | $ | 972 | $ | 2,735 | $ | 2,810 | ||||||||
Master Settlement Agreement and other state settlement expense | $ | 524 | $ | 532 | $ | 1,436 | $ | 1,321 | ||||||||
Federal tobacco buyout expense | $ | 52 | $ | 51 | $ | 158 | $ | 157 | ||||||||
FDA fees | $ | 32 | $ | 31 | $ | 99 | $ | 94 | ||||||||
Schedule 2
REYNOLDS AMERICAN INC.
Reconciliation of GAAP to Adjusted Results
(Dollars in Millions, Except Per Share Amounts)
(Unaudited)
RAI management uses “adjusted” (non-GAAP) measurements to set performance goals and to measure the performance of the overall company, and believes that investors’ understanding of the underlying performance of the company’s continuing operations is enhanced through the disclosure of these metrics. “Adjusted” (non-GAAP) results are not, and should not be viewed as, substitutes for “reported” (GAAP) results.
| Three Months Ended September 30, | ||||||||||||||||||||||||
| 2014 | 2013 | |||||||||||||||||||||||
| Operating | Net | Diluted | Operating | Net | Diluted | |||||||||||||||||||
| Income | Income | EPS | Income | Income | EPS | |||||||||||||||||||
GAAP results | $ | 812 | $ | 467 | $ | 0.88 | $ | 791 | $ | 457 | $ | 0.84 | ||||||||||||
The GAAP results include the following: | ||||||||||||||||||||||||
Implementation costs | 4 | 3 | - | 3 | 2 | - | ||||||||||||||||||
Engle Progeny cases | 13 | 8 | 0.02 | 10 | 6 | 0.01 | ||||||||||||||||||
Tobacco Related and Other Litigation | - | - | - | 4 | 3 | 0.01 | ||||||||||||||||||
Transaction related costs | 23 | 18 | 0.03 | - | - | - | ||||||||||||||||||
Financing costs | - | 9 | 0.02 | - | - | - | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total adjustments | 40 | 38 | 0.07 | 17 | 11 | 0.02 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Adjusted results | $ | 852 | $ | 505 | $ | 0.95 | $ | 808 | $ | 468 | $ | 0.86 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
| Nine Months Ended September 30, | ||||||||||||||||||||||||
| 2014 | 2013 | |||||||||||||||||||||||
| Operating | Net | Diluted | Operating | Net | Diluted | |||||||||||||||||||
| Income | Income | EPS | Income | Income | EPS | |||||||||||||||||||
GAAP results | $ | 2,238 | $ | 1,322 | $ | 2.47 | $ | 2,476 | $ | 1,426 | $ | 2.60 | ||||||||||||
The GAAP results include the following: | ||||||||||||||||||||||||
One-time benefit from the NPM Partial Settlement | (34 | ) | (21 | ) | (0.04 | ) | (219 | ) | (124 | ) | (0.23 | ) | ||||||||||||
Implementation costs | 12 | 8 | 0.02 | 15 | 10 | 0.02 | ||||||||||||||||||
Gain on discontinued operations | - | (25 | ) | (0.05 | ) | - | - | - | ||||||||||||||||
Engle Progeny cases | 84 | 53 | 0.10 | 17 | 10 | 0.02 | ||||||||||||||||||
Tobacco Related and Other Litigation | 2 | 1 | - | 9 | 6 | 0.01 | ||||||||||||||||||
Transaction related costs | 23 | 18 | 0.03 | - | - | - | ||||||||||||||||||
Financing costs | - | 9 | 0.02 | - | - | - | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total adjustments | 87 | 43 | 0.08 | (178 | ) | (98 | ) | (0.18 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Adjusted results | $ | 2,325 | $ | 1,365 | $ | 2.55 | $ | 2,298 | $ | 1,328 | $ | 2.42 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Condensed Consolidated Balance Sheets |
| |||||||||||||||||||||||
| (Dollars in Millions) | ||||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||||
| Sept. 30, | Dec. 31, | |||||||||||||||
| 2014 | 2013 | |||||||||||||||
Assets | ||||||||||||||||
Cash and cash equivalents | $ | 1,289 | $ | 1,500 | ||||||||||||
Other current assets | 2,167 | 2,155 | ||||||||||||||
Trademarks and other intangible assets, net | 2,424 | 2,417 | ||||||||||||||
Goodwill | 8,017 | 8,011 | ||||||||||||||
Other noncurrent assets | 1,435 | 1,319 | ||||||||||||||
|
|
|
| |||||||||||||
| $ | 15,332 | $ | 15,402 | |||||||||||||
|
|
|
| |||||||||||||
Liabilities and shareholders’ equity | ||||||||||||||||
Tobacco settlement accruals | $ | 1,703 | $ | 1,727 | ||||||||||||
Other current liabilities | 1,583 | 1,349 | ||||||||||||||
Long-term debt (less current maturities) | 5,087 | 5,099 | ||||||||||||||
Deferred income taxes, net | 715 | 658 | ||||||||||||||
Long-term retirement benefits (less current portion) | 1,134 | 1,221 | ||||||||||||||
Other noncurrent liabilities | 117 | 181 | ||||||||||||||
Shareholders’ equity | 4,993 | 5,167 | ||||||||||||||
|
|
|
| |||||||||||||
| $ | 15,332 | $ | 15,402 | |||||||||||||
|
|
|
| |||||||||||||
Schedule 3
REYNOLDS AMERICAN INC.
Reconciliation of GAAP to Adjusted Operating Income by Segment
(Dollars in Millions)
(Unaudited)
The R.J. Reynolds segment consists of the primary operations of R.J. Reynolds Tobacco Company, the second-largest tobacco company in the United States and which also manages a contract manufacturing business.
The American Snuff segment consists of the primary operations of American Snuff Company, LLC, the second-largest smokeless tobacco products manufacturer in the United States.
The Santa Fe segment consists of the primary operations of Santa Fe Natural Tobacco Company, Inc., which manufactures Natural American Spirit cigarettes and other additive-free tobacco products.
Management uses “adjusted” (non-GAAP) measurements to set performance goals and to measure the performance of the company, and believes that investors’ understanding of the underlying performance of the company’s continuing operations is enhanced through the disclosure of these metrics.
| Three Months Ended September 30, | ||||||||||||||||||||||||
| 2014 | 2013 | |||||||||||||||||||||||
| R.J. Reynolds | American Snuff | Santa Fe | R.J. Reynolds | American Snuff | Santa Fe | |||||||||||||||||||
GAAP operating income | $ | 731 | $ | 117 | $ | 98 | $ | 635 | $ | 106 | $ | 82 | ||||||||||||
The GAAP results include the following: | ||||||||||||||||||||||||
Implementation costs | 4 | - | - | 3 | - | - | ||||||||||||||||||
Engle Progeny cases | 13 | - | - | 10 | - | - | ||||||||||||||||||
Tobacco Related and Other Litigation | - | - | - | 4 | - | - | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total adjustments (2) | 17 | - | - | 17 | - | - | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Adjusted operating income | $ | 748 | $ | 117 | $ | 98 | $ | 652 | $ | 106 | $ | 82 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
| Nine Months Ended September 30, | ||||||||||||||||||||||||
| 2014 | 2013 | |||||||||||||||||||||||
| R.J. Reynolds | American Snuff | Santa Fe | R.J. Reynolds | American Snuff | Santa Fe | |||||||||||||||||||
GAAP operating income | $ | 1,939 | $ | 329 | $ | 247 | $ | 2,056 | $ | 306 | $ | 208 | ||||||||||||
The GAAP results include the following: | ||||||||||||||||||||||||
One-time benefit from the NPM Partial Settlement | (34 | ) | - | - | (217 | ) | - | (2 | ) | |||||||||||||||
Implementation costs | 12 | - | - | 12 | 2 | 1 | ||||||||||||||||||
Engle Progeny cases | 84 | - | - | 17 | - | - | ||||||||||||||||||
Tobacco Related and Other Litigation (1) | - | - | - | 9 | - | - | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total adjustments (2) | 62 | - | - | (179 | ) | 2 | (1 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Adjusted operating income | $ | 2,001 | $ | 329 | $ | 247 | $ | 1,877 | $ | 308 | $ | 207 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
(1) For the nine months ended September 30, 2014, RAI and its operating companies recorded aggregate adjustments of $2 million in tobacco related and other litigation charges, which is included in corporate costs.
(2) For the three and nine months ended September 30, 2014, RAI and its operating companies recorded aggregate adjustments of $23 million in transaction related costs which are included in corporate costs.
Schedule 4
R.J. REYNOLDS CIGARETTE VOLUMES AND RETAIL SHARE OF MARKET
| VOLUME (in billions): | Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||
September 30, |
Change |
September 30, |
Change | |||||||||||||||||||||||||||||
| 2014 | 2013 | Units | % | 2014 | 2013 | Units | % | |||||||||||||||||||||||||
Camel | 5.7 | 5.5 | 0.2 | 3.0% | 15.8 | 15.8 | 0.0 | 0.3% | ||||||||||||||||||||||||
Pall Mall | 5.5 | 5.6 | (0.1) | -1.5% | 15.6 | 16.0 | (0.4) | -2.7% | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
Total growth brands | 11.1 | 11.1 | 0.1 | 0.7% | 31.4 | 31.8 | (0.4) | -1.2% | ||||||||||||||||||||||||
Other | 5.0 | 5.6 | (0.6) | -10.1% | 14.7 | 16.8 | (2.1) | -12.4% | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
Total R.J. Reynolds domestic | 16.2 | 16.7 | (0.5) | -2.9% | 46.1 | 48.6 | (2.5) | -5.1% | ||||||||||||||||||||||||
Total premium | 9.5 | 9.7 | (0.2) | -1.9% | 26.9 | 28.2 | (1.3) | -4.5% | ||||||||||||||||||||||||
Total value | 6.7 | 7.0 | (0.3) | -4.4% | 19.2 | 20.4 | (1.2) | -5.8% | ||||||||||||||||||||||||
Premium/total mix | 58.6% | 57.9% | 0.6% | 58.4% | 58.1% | 0.3% | ||||||||||||||||||||||||||
Industry | 70.7 | 72.3 | (1.6) | -2.3% | 199.2 | 206.5 | (7.3) | -3.5% | ||||||||||||||||||||||||
Premium | 50.0 | 51.1 | (1.2) | -2.3% | �� | 142.0 | 146.7 | (4.7) | -3.2% | |||||||||||||||||||||||
Value | 20.7 | 21.2 | (0.5) | -2.3% | 57.2 | 59.8 | (2.6) | -4.4% | ||||||||||||||||||||||||
Premium/total mix | 70.7% | 70.7% | 0.0% | 71.3% | 71.0% | 0.2% | ||||||||||||||||||||||||||
RETAIL SHARE OF MARKET *: | Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||
September 30, |
September 30, | |||||||||||||||||||||||||||||||
| 2014 | 2013 | Change | 2014 | 2013 | Change | |||||||||||||||||||||||||||
Camel | 10.4% | 10.0% | 0.4 | 10.2% | 9.8% | 0.4 | ||||||||||||||||||||||||||
Pall Mall | 9.3% | 9.4% | (0.1) | 9.4% | 9.3% | 0.1 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
Total growth brands | 19.7% | 19.4% | 0.3 | 19.5% | 19.0% | 0.5 | ||||||||||||||||||||||||||
Other | 6.9% | 7.3% | (0.4) | 7.0% | 7.6% | (0.5) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
Total R.J. Reynolds domestic | 26.6% | 26.7% | (0.1) | 26.6% | 26.6% | (0.0) | ||||||||||||||||||||||||||
* As noted earlier this year, the projection universe that the company’s vendor uses to estimate RAI’s operating companies’ retail cigarette market shares has been revised for 2014, with the primary focus now on the convenience/gas channel, where the majority of tobacco products are purchased and brand-support investments are made. This revision resulted in higher absolute share levels on some of the companies’ key brands, but does not affect overall share trends.
Amounts are rounded on an individual basis and, accordingly, may not sum in the aggregate.
Industry volume data based on information from Management Science Associates, Inc.
Retail shares of market are as reported by Information Resources Inc./Capstone.
Schedule 5
AMERICAN SNUFF MOIST-SNUFF VOLUMES
AND RETAIL SHARE OF MARKET
VOLUME (in millions of cans):
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||
| September 30, | Change | September 30, | Change | |||||||||||||||||||||||||||||
| 2014 | 2013 | Units | % | 2014 | 2013 | Units | % | |||||||||||||||||||||||||
Grizzly | 108.7 | 105.0 | 3.7 | 3.6% | 324.6 | 309.5 | 15.1 | 4.9% | ||||||||||||||||||||||||
Other | 11.3 | 11.7 | (0.4) | -3.3% | 33.6 | 34.6 | (1.0) | -2.9% | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
Total moist snuff cans | 120.1 | 116.7 | 3.4 | 2.9% | 358.2 | 344.1 | 14.1 | 4.1% | ||||||||||||||||||||||||
RETAIL SHARE OF MARKET *: | ||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||
| 2014 | 2013 | Change | 2014 | 2013 | Change | |||||||||||||||||||||||||||
Grizzly | 31.1% | 31.0% | 0.1 | 31.4% | 30.7% | 0.7 | ||||||||||||||||||||||||||
Other | 2.9% | 3.1% | (0.2) | 3.0% | 3.2% | (0.2) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
Total retail share of market | 34.0% | 34.2% | (0.1) | 34.4% | 33.9% | 0.5 | ||||||||||||||||||||||||||
SANTA FE CIGARETTE VOLUMES AND RETAIL SHARE OF MARKET
VOLUME (in billions):
|
| |||||||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||
| September 30, | Change | September 30, | Change | |||||||||||||||||||||||||||||
| 2014 | 2013 | Units | % | 2014 | 2013 | Units | % | |||||||||||||||||||||||||
Natural American Spirit | 1.1 | 1.0 | 0.1 | 7.9% | 2.9 | 2.7 | 0.2 | 8.7% | ||||||||||||||||||||||||
| RETAIL SHARE OF MARKET *: | ||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||
| 2014 | 2013 | Change | 2014 | 2013 | Change | |||||||||||||||||||||||||||
Natural American Spirit | 1.7% | 1.5% | 0.2 | 1.6% | 1.4% | 0.2 | ||||||||||||||||||||||||||
* As noted earlier this year, the projection universe that the company’s vendor uses to estimate RAI’s operating companies’ retail cigarette market shares has been revised for 2014, with the primary focus now on the convenience/gas channel, where the majority of tobacco products are purchased and brand-support investments are made. This revision resulted in higher absolute share levels on some of the companies’ key brands, but does not affect overall share trends.
Amounts are rounded on an individual basis and, accordingly, may not sum in the aggregate.
Retail shares of market are as reported by Information Resources Inc./Capstone.
Cautionary Statement Regarding Forward-Looking Statements
Statements included in this communication that are not historical in nature constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. When used in this communication and in documents incorporated by reference, forward-looking statements include, without limitation, statements regarding the benefits of the Proposed Transactions, including future financial and operating results, the combined company’s plans, expectations, beliefs, intentions and future strategies, and other statements that are not historical facts, that are signified by the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. These statements regarding future events or the future performance or results of the combined company inherently are subject to a variety of risks, contingencies and uncertainties that could cause actual results, performance or achievements to differ materially from those described in or implied in the forward-looking statements.
Among the risks, contingencies and uncertainties that could cause actual results to differ from those described in the forward-looking statements or could result in the failure of the of the proposed transactions (the Proposed Transactions), relating to the consummation of the previously announced Proposed Transactions with Reynolds American, Lorillard, Inc. (Lorillard), Imperial Tobacco Group PLC (Imperial), Lignum-2, L.L.C. (Imperial Sub), a wholly owned subsidiary of Imperial, and British American Tobacco p.l.c. (BAT), to be consummated or, if consummated, could have an adverse effect on the results of operations, cash flows and financial position of Reynolds American, are the following: the failure to obtain necessary regulatory or other approvals for the Proposed Transactions, or if obtained, the possibility of being subjected to conditions that could reduce the expected synergies and other benefits of the Proposed Transactions, result in a material delay in, or the abandonment of, the Proposed Transactions or otherwise have an adverse effect on Reynolds American; the obligation to complete the Proposed Transactions even if financing is not available or is available on terms other than those currently anticipated, including financing less favorable to Reynolds American than its current commitments, due to the absence of a financing condition in connection with the Proposed Transactions; the obligation to complete the Proposed Transactions even if there are adverse governmental developments with respect to menthol in cigarettes, and, once completed, the effect of such adverse governmental developments on Reynolds American’s subsidiaries’ sales of products that contain menthol which will represent a substantial portion of Reynolds American’s consolidated sales; the failure to satisfy required closing conditions or complete the Proposed Transactions in a timely manner; the failure to obtain necessary shareholder approvals for the Proposed Transactions; the failure to obtain Imperial shareholder approval for the divestiture transaction and the possibility of needing an alternative divestiture partner; the possibility of selling the transferred assets, including the brands currently expected to be divested, or which otherwise might be divested (in each case, subject to Reynolds American’s binding obligations under the asset purchase agreement to complete the divestiture transaction), on terms less favorable than the divestiture transaction, due to the absence of a condition in connection with the Proposed Transactions be completed; the possibility of having to include RJR Tobacco’s DORAL brand as part of the divestiture transaction; the effect of the announcement of the Proposed Transactions on the ability to retain and hire key personnel, maintain business relationships, and on operating results and businesses generally; the effect of restrictions placed on Reynolds
American’s, Lorillard’s or their respective subsidiaries’ business activities and the limitations put on Reynolds American’s and Lorillard’s ability to pursue alternatives to the Proposed Transactions pursuant to the merger agreement and the asset purchase agreement; the possibility of delay or prevention of the Proposed Transactions by lawsuits challenging the Proposed Transactions filed against Reynolds American, the members of the Reynolds American board of directors, Lorillard, the members of the Lorillard board of directors and BAT; the uncertainty of the value of the merger consideration that Lorillard shareholders will receive in the Proposed Transactions due to a fixed exchange ratio and a potential fluctuation in the market price of Reynolds American common stock; the reliance of RJR Tobacco on Imperial Sub to manufacture Newport on RJR Tobacco’s behalf for a period of time after the divestiture transaction; Reynolds American’s obligations to indemnify Imperial Sub for specified matters and to retain certain liabilities related to the transferred assets; the possibility of Reynolds American’s and Lorillard’s directors and officers having interests in the Proposed Transactions that are different from, or in addition to, the interests of Reynolds American and Lorillard shareholders generally; the possibility of changes in circumstances between the date of the signing of the merger agreement and the closing of the Proposed Transactions that will not be reflected in the fairness opinions obtained by the boards of directors of Reynolds American and Lorillard from their respective advisors; a termination of the governance agreement or certain provisions of it in accordance with its terms, including the limitations on Brown & Williamson Holdings, Inc.’s (B&W) representation on the Reynolds American board of directors and its board committees; the effect of the substantial additional indebtedness that Reynolds American will incur in connection with the Proposed Transactions; the continuing decline in volume in the U.S. cigarette industry and Reynolds American’s dependence on the U.S. cigarette industry; the impact of BAT’s significant beneficial ownership in Reynolds American, the related governance agreement among Reynolds American, BAT and B&W and the provisions favoring BAT in the Reynolds American articles of incorporation on Reynolds American’s business, the Reynolds American board of directors and other Reynolds American shareholders; the possibility of actual results of operations, cash flows and financial position after the Proposed Transactions materially differing from the Reynolds American unaudited pro forma condensed combined financial statements; the difference in rights provided to Lorillard shareholders under Delaware law, the Lorillard certificate of incorporation and the Lorillard by-laws, as compared to the rights Lorillard shareholders will obtain as Reynolds American shareholders under North Carolina law, the Reynolds American articles of incorporation, the Reynolds American bylaws and the governance agreement; the failure to realize projected synergies and other benefits from the Proposed Transactions; the incurrence of significant pre- and post-transaction related costs in connection with the Proposed Transactions; and the occurrence of any event giving rise to the right of a party to terminate the Proposed Transactions. Discussions of additional risks, contingencies and uncertainties are contained in Reynolds American’s and Lorillard’s filings with the Securities and Exchange Commission (the SEC).
Due to these risks, contingencies and other uncertainties, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of such statements. Except as provided by federal securities laws, Reynolds American is under no obligation to, and expressly disclaims any obligation, to update, alter or otherwise revise any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future events or otherwise.
Additional Information
Reynolds American filed with the SEC a registration statement on Form S-4 that includes the Joint Proxy Statement of Reynolds American and Lorillard that also constitutes a prospectus of Reynolds American. Reynolds American and Lorillard plan to mail to their respective shareholders the Joint Proxy Statement/Prospectus in connection with the Proposed Transactions. INVESTORS AND SHAREHOLDERS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC CAREFULLY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT REYNOLDS AMERICAN, LORILLARD, THE PROPOSED TRANSACTIONS AND RELATED MATTERS. Investors and shareholders are able to obtain free copies of the Joint Proxy Statement/Prospectus and other documents filed with the SEC by Reynolds American and Lorillard through the website maintained by the SEC at www.sec.gov. In addition, investors and shareholders are able to obtain free copies of the Joint Proxy Statement/Prospectus and other documents filed with the SEC by Reynolds American by contacting Reynolds American Investor Relations at raiinvestorrelations@reynoldsamerican.com or by calling (336)741-5165 or at Reynolds American’s website at www.reynoldsamerican.com, and are be able to obtain free copies of the Joint Proxy Statement/Prospectus and other documents filed with the SEC by Lorillard by contacting Lorillard Investor Relations at investorrelations@lortobco.com or by calling (336)335-7000 or at Lorillard’s website at www.lorillard.com.
This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the acquisition, the merger or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
Reynolds American and Lorillard and certain of their respective directors and executive officers and employees may be considered participants in the solicitation of proxies from the respective shareholders of Reynolds American and stockholders of Lorillard in respect of the Proposed Transactions contemplated by the Joint Proxy Statement/Prospectus. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the respective shareholders of Reynolds American and stockholders of Lorillard in connection with the Proposed Transactions, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in the Joint Proxy Statement/Prospectus filed with the SEC. Information regarding Reynolds American’s directors and executive officers is contained in Reynolds American’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013, which is filed with the SEC. Information regarding Lorillard’s directors and executive officers is contained in Lorillard’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013, which is filed with the SEC.